Literature DB >> 9715504

The National Toxicology Program evaluation of genetically altered mice as predictive models for identifying carcinogens.

W C Eastin1, J K Haseman, J F Mahler, J R Bucher.   

Abstract

National Institute of Environmental Health Sciences researchers are exploring the utility of genetically altered mice to study mechanisms of carcinogenesis. Two of these mouse models, the Tg.AC (carrier of an activated mouse H-ras oncogene) and the p53+/- (heterozygous for the wild-type tumor suppressor gene Trp53), have genetic alterations that appear to hasten their expression of chemically induced tumors. These 2 models have been proposed as a basis for new strategies for identifying chemical carcinogens and for assessing risk. The National Toxicology Program (NTP) is conducting a series of studies with these 2 genetically altered strains to further examine their strengths and weaknesses for identification of documented rodent and human carcinogens. In this first evaluation, candidates for study were drawn from the NTP historical database of 2-yr rodent carcinogenicity studies and the open literature (primarily for drugs). Results with this first set of 11 chemicals tested in genetically altered mice, compared with previous findings in the traditional 2-yr rodent assays and literature on human tumor findings, appear to support the premise advanced by Tennant et al that these models have the potential to serve as more rapid and less expensive test systems to identify carcinogens.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715504     DOI: 10.1177/019262339802600401

Source DB:  PubMed          Journal:  Toxicol Pathol        ISSN: 0192-6233            Impact factor:   1.902


  5 in total

1.  Proceedings of the 2009 National Toxicology Program Satellite Symposium.

Authors:  Ute Bach; James R Hailey; Georgette D Hill; Wolfgang Kaufmann; Kenneth S Latimer; David E Malarkey; Robert M Maronpot; Rodney A Miller; Rebecca R Moore; James P Morrison; Thomas Nolte; Matthias Rinke; Susanne Rittinghausen; Andrew W Suttie; Gregory S Travlos; John L Vahle; Gabrielle A Willson; Susan A Elmore
Journal:  Toxicol Pathol       Date:  2009-12-15       Impact factor: 1.902

Review 2.  The use of genetically modified mice in cancer risk assessment: challenges and limitations.

Authors:  David A Eastmond; Suryanarayana V Vulimiri; John E French; Babasaheb Sonawane
Journal:  Crit Rev Toxicol       Date:  2013-09       Impact factor: 5.635

3.  Evaluation of dichloroacetic acid for carcinogenicity in genetically modified Tg.AC hemizygous and p53 haploinsufficient mice.

Authors:  Grace E Kissling; David E Malarkey; Molly K Vallant; Jerry D Johnson; Milton R Hejtmancik; Ronald A Herbert; Gary A Boorman
Journal:  Toxicol Sci       Date:  2008-10-30       Impact factor: 4.849

4.  Dose-dependent mesothelioma induction by intraperitoneal administration of multi-wall carbon nanotubes in p53 heterozygous mice.

Authors:  Atsuya Takagi; Akihiko Hirose; Mitsuru Futakuchi; Hiroyuki Tsuda; Jun Kanno
Journal:  Cancer Sci       Date:  2012-06-21       Impact factor: 6.716

Review 5.  The role of transgenic mouse models in carcinogen identification.

Authors:  John B Pritchard; John E French; Barbara J Davis; Joseph K Haseman
Journal:  Environ Health Perspect       Date:  2003-04       Impact factor: 9.031

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.